Ameriprise’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.7M | Buy |
577,125
+35,086
| +6% | +$1.54M | 0.01% | 1197 |
|
|
2025
Q4 | $20.9M | Buy |
542,039
+131,965
| +32% | +$5.03M | ﹤0.01% | 1386 |
|
|
2025
Q3 | $14.5M | Buy |
410,074
+239,346
| +140% | +$8.66M | ﹤0.01% | 1633 |
|
|
2025
Q2 | $6.15M | Buy |
170,728
+148,752
| +677% | +$4.93M | ﹤0.01% | 2208 |
|
|
2025
Q1 | $684K | Sell |
21,976
-2,256
| -9% | -$71.5K | ﹤0.01% | 3374 |
|
|
2024
Q4 | $618K | Sell |
24,232
-23,786
| -50% | -$631K | ﹤0.01% | 3443 |
|
|
2024
Q3 | $1.36M | Buy |
48,018
+3,024
| +7% | +$83.8K | ﹤0.01% | 3089 |
|
|
2024
Q2 | $1.19M | Sell |
44,994
-132,364
| -75% | -$3.67M | ﹤0.01% | 3088 |
|
|
2024
Q1 | $5.39M | Buy |
177,358
+10,806
| +6% | +$319K | ﹤0.01% | 2313 |
|
|
2023
Q4 | $4.68M | Sell |
166,552
-2,271,500
| -93% | -$62.4M | ﹤0.01% | 2394 |
|
|
2023
Q3 | $66.2M | Buy |
2,438,052
+229,165
| +10% | +$6.81M | 0.02% | 640 |
|
|
2023
Q2 | $67.9M | Buy |
2,208,887
+723,451
| +49% | +$24.5M | 0.02% | 635 |
|
|
2023
Q1 | $53.5M | Buy |
1,485,436
+98,288
| +7% | +$3.64M | 0.02% | 724 |
|
|
2022
Q4 | $54.8M | Buy |
1,387,148
+12,907
| +0.9% | +$539K | 0.02% | 688 |
|
|
2022
Q3 | $55.2M | Buy |
1,374,241
+84,542
| +7% | +$3.61M | 0.02% | 663 |
|
|
2022
Q2 | $54.2M | Sell |
1,289,699
-2,418
| -0.2% | -$99.1K | 0.02% | 686 |
|
|
2022
Q1 | $50.3M | Sell |
1,292,117
-8,554
| -0.7% | -$336K | 0.01% | 810 |
|
|
2021
Q4 | $51.8M | Buy |
1,300,671
+8,410
| +0.7% | +$327K | 0.01% | 825 |
|
|
2021
Q3 | $46.7M | Sell |
1,292,261
-59,915
| -4% | -$2.33M | 0.01% | 799 |
|
|
2021
Q2 | $55.4M | Buy |
1,352,176
+88,292
| +7% | +$3.76M | 0.02% | 749 |
|
|
2021
Q1 | $55.2M | Buy |
1,263,884
+471,201
| +59% | +$22.3M | 0.02% | 730 |
|
|
2020
Q4 | $39.7M | Buy |
792,683
+171,965
| +28% | +$7.3M | 0.01% | 855 |
|
|
2020
Q3 | $26.1M | Sell |
620,718
-804,652
| -56% | -$34.5M | 0.01% | 937 |
|
|
2020
Q2 | $69.2M | Buy |
+1,425,370
| New | +$70.6M | 0.03% | 501 |
|